VITROS® MicroSlide Assay Summary Pub. No.

J23323_EN
2020-02-21

Reaction Sample

Recommended

Slide Supply

On-Analyzer
Volume (µL)
Specimens2

Filter (nm)
Calibrator
Suggested Reference Interval or

Stability
Control

Diluent
Measuring Cutoff
Test Name/ (Reportable or Dynamic) Refer to the Instructions for Use for Long-term Reagent
Abbreviation Range further Interpretation of Results Storage3
− Serum 10 9 TDM PV Specialty Diluent 10–200 μg/mL Therapeutic: 670 2 ≤5 weeks Frozen
ACET
− Heparin 66–1323 μmol/L 10–30 μg/mL 66–199 μmol/L
Acetaminophen plasma FS Diluent Pack 3
(μmol/L = μg/mL x 6.616) Possible Toxicity:
− EDTA plasma 150 –200 μg/mL 992–1323 μmol/L
Probable Toxicity:
> 200 μg/mL > 1323 μmol/L
− Serum 5.5 4 PV Isotonic saline or 1.00–6.00 g/dL 3.5–5.0 g/dL 35–50 g/L 630 1 ≤1 week Frozen or Refrigerated
ALB
− Heparin Reagent-grade 10.0-60.0 g/L
Albumin plasma water (g/L = g/dL x 10)

− Serum 4.2 4 PV Isotonic saline or 1.0–6.0 g/dL 3.5–5.0 g/dL 35–50 g/L 630 1 ≤1 week Frozen or Refrigerated
XT ALB5
− Heparin Reagent-grade 10-60 g/L
Albumin (Lithium and water (g/L = g/dL x 10)
Sodium)
plasma
− Serum 10 8 Liquid PV 7% BSA 10–300 mg/dL Negative: 340 2 ≤1 week Frozen
ALC
− Heparin 2.2–65.1 mmol/L <10 mg/dL <2 mmol/L
Alcohol plasma FS Diluent Pack 2
(mmol/L = mg/dL x 0.217) Toxic:
− Fluoride 50–100 mg/dL 11–22 mmol/L
Oxalate Depression of CNS:
plasma
>100 mg/dL >22 mmol/L
Fatalities
Reported:
>400 mg/dL >87 mmol/L
− Serum 11 3 PV 7% BSA 20–1500 U/L 38–126 U/L 400 2 ≤2 weeks Frozen or Refrigerated
ALKP
− Heparin
Alkaline plasma FS Diluent Pack 2
Phosphatase
− Serum 5.0 3 PV 7% BSA 20–1500 U/L 38–126 U/L 400 2 ≤2 weeks Frozen or Refrigerated
XT ALKP5
− Heparin
Alkaline (Lithium and FS Diluent Pack 2
Phosphatase Sodium)
plasma

This information was current as of the publication date. The Instructions for Use are the authorized source for information about VITROS Chemistry Products. Not all products and systems are available in all countries.
1
See Instructions for Use for the special dilution procedure.
2
See Instructions for Use for specimen Interferent information.
3
Minimum warm-up time to room temperature is 60 minutes if frozen and 30 minutes if refrigerated.
4
Minimum warm-up time for Na+ is 120 minutes if frozen and 90 minutes if refrigerated.
5
This assay is only approved for use on the VITROS XT 7600 Integrated System.

© Ortho-Clinical Diagnostics, Inc., 2020 • VITROS is a registered trademark of Ortho-Clinical Diagnostics, Inc. • 100 Indigo Creek Drive • Rochester, NY 14626 1
 VITROS® MicroSlide Assay Summary Pub. No. J23323_EN
2020-02-21

Reaction Sample

Recommended

Slide Supply

On-Analyzer
Volume (µL)
Specimens2

Filter (nm)
Calibrator
Suggested Reference Interval or

Stability
Control

Diluent
Measuring Cutoff
Test Name/ (Reportable or Dynamic) Refer to the Instructions for Use for Long-term Reagent
Abbreviation Range further Interpretation of Results Storage3
− Serum 11 3 PV 7% BSA 6–1000 U/L Adult: 13–69 U/L 340 2 ≤ 4 weeks Frozen or Refrigerated
ALT
− Heparin FS Diluent Pack 2 Female: 9–52 U/L
Alanine plasma Male: 21–72 U/L
Aminotransferase − EDTA plasma
− Serum 7 3 PV 7% BSA 4-750 U/L Female: <35 U/L 670 2 ≤ 2 weeks Frozen or
ALTV
− Heparin FS Diluent Pack 2 Male: <50 U/L Refrigerated ≤ 3 months
Alanine plasma
Aminotransferase
− Serum 3.5 3 PV 7% BSA 4-750 U/L Female: <35 U/L 670 2 ≤ 2 weeks Frozen or
XT ALTV5
− Heparin FS Diluent Pack 2 Male: <50 U/L Refrigerated ≤ 3 months
Alanine (Lithium and
Aminotransferase Sodium)
plasma
− Heparin 10 5 Liquid PV Reagent-grade 8.7–500.0 μmol/L 9–30 μmol/L 600 2 ≤ 1 week Frozen
AMON
plasma water
Ammonia − EDTA plasma FS Diluent Pack 3
− Serum 10 3 PV Specialty Diluent or 30–1200 U/L Adult: 30–110 U/L 540 1 ≤ 2 weeks Frozen or
AMYL
− Heparin low patient sample Refrigerated ≤ 4 weeks
Amylase plasma
FS Diluent Pack 3
− Urine Isotonic saline 30–1200 U/L 32–641 U/L
FS Diluent Pack 2
− Serum 7 3 PV 7% BSA 3.0–750.0 U/L Adult: 15–46 U/L 670 2 ≤ 2 weeks Frozen or
AST
− Heparin FS Diluent Pack 2 Female: 14–36 U/L Refrigerated ≤ 3 months
Aspartate plasma
Aminotransferase Male: 17–59 U/L
− Serum 3.3 3 PV 7% BSA 3–750 U/L Adult: 15–46 U/L 670 2 ≤ 2 weeks Frozen or
XT AST5
− Heparin FS Diluent Pack 2 Female: 14–36 U/L Refrigerated ≤ 3 months
Aspartate (Lithium and
Aminotransferase Sodium) Male: 17–59 U/L
plasma

This information was current as of the publication date. The Instructions for Use are the authorized source for information about VITROS Chemistry Products. Not all products and systems are available in all countries.
1
See Instructions for Use for the special dilution procedure.
2
See Instructions for Use for specimen Interferent information.
3
Minimum warm-up time to room temperature is 60 minutes if frozen and 30 minutes if refrigerated.
4
Minimum warm-up time for Na+ is 120 minutes if frozen and 90 minutes if refrigerated.
5
This assay is only approved for use on the VITROS XT 7600 Integrated System.

© Ortho-Clinical Diagnostics, Inc., 2020 • VITROS is a registered trademark of Ortho-Clinical Diagnostics, Inc. • 100 Indigo Creek Drive • Rochester, NY 14626 2
 VITROS® MicroSlide Assay Summary Pub. No. J23323_EN
2020-02-21

Reaction Sample

Recommended

Slide Supply

On-Analyzer
Volume (µL)
Specimens2

Filter (nm)
Calibrator
Suggested Reference Interval or

Stability
Control

Diluent
Measuring Cutoff
Test Name/ (Reportable or Dynamic) Refer to the Instructions for Use for Long-term Reagent
Abbreviation Range further Interpretation of Results Storage3
− Serum 10 4 PV 7% BSA or normal Bu: 0.0–27.0 mg/dL Adult: 400 1 ≤ 2 weeks Frozen or Refrigerated
BuBc
− Heparin patient sample 0–462 μmol/L Bu: 0.0–1.1 mg/dL 0–19 μmol/L &
Bilirubin, plasma FS Diluent Pack 2 Bc: 0.0–27.0 mg/dL Bc: 0.0–0.3 mg/dL 0–5 μmol/L 460
unconjugated and
0–462 μmol/L Neonate:
conjugated
(μmol/L = mg/dL x 17.1) Bu: 0.6–10.5 mg/dL 10–180 μmol/L
Bc: 0.0–0.6 mg/dL 0–10 μmol/L
− Serum 5.5 1 PV 7% BSA 2.0–120.0 mg/dL (urea N) Male: 670 1 ≤ 2 weeks Frozen or Refrigerated
BUN/UREA
− Heparin FS Diluent Pack 2 0.71–42.83 mmol/L (urea) 9–20 mg/dL (urea N) 3.2–7.1 mmol/L
Blood Urea plasma (mmol/L = mg/dL x 0.3569) (urea)
Nitrogen − EDTA plasma Female:
7–17 mg/dL (urea N)
2.5–6.1 mmol/L
(urea)
− Urine (diluted) Isotonic saline1
or 67–2520 mg/dL (urea N) 24 Hour:
Reagent-grade 23.91–899.39 mmol/L (urea) 12–20 g/day 428–714
water1
after x21 dilution with water (urea N) mmol/day (urea)
FS Diluent Pack 3 (mmol/L = mg/dL x 0.3569)

− Serum 4.3 1 PV 7% BSA 2.0–120.0 mg/dL (urea N) Male: 670 2 ≤ 2 weeks Frozen or
XT UREA5
− Heparin FS Diluent Pack 2 0.71–42.83 mmol/L (urea) 9–20 mg/dL (urea N) 3.2–7.1 mmol/L Refrigerated ≤ 4 weeks
Urea (Lithium and (mmol/L = mg/dL x 0.3569) (urea)
Sodium) Female:
plasma
7–17 mg/dL (urea N)
2.5–6.1 mmol/L
(urea)

− Urine (diluted) Isotonic saline1 or 67–2520 mg/dL (urea N) 24 Hour: 428–714

Reagent-grade 23.91–899.39 mmol/L (urea) 12–20 g/day mmol/day (urea)
water1 after x21 dilution with water (urea N)
FS Diluent Pack 3 (mmol/L = mg/dL x 0.3569)

This information was current as of the publication date. The Instructions for Use are the authorized source for information about VITROS Chemistry Products. Not all products and systems are available in all countries.
1
See Instructions for Use for the special dilution procedure.
2
See Instructions for Use for specimen Interferent information.
3
Minimum warm-up time to room temperature is 60 minutes if frozen and 30 minutes if refrigerated.
4
Minimum warm-up time for Na+ is 120 minutes if frozen and 90 minutes if refrigerated.
5
This assay is only approved for use on the VITROS XT 7600 Integrated System.

© Ortho-Clinical Diagnostics, Inc., 2020 • VITROS is a registered trademark of Ortho-Clinical Diagnostics, Inc. • 100 Indigo Creek Drive • Rochester, NY 14626 3
 VITROS® MicroSlide Assay Summary Pub. No. J23323_EN
2020-02-21

Reaction Sample

Recommended

Slide Supply

On-Analyzer
Volume (µL)
Specimens2

Filter (nm)
Calibrator
Suggested Reference Interval or

Stability
Control

Diluent
Measuring Cutoff
Test Name/ (Reportable or Dynamic) Refer to the Instructions for Use for Long-term Reagent
Abbreviation Range further Interpretation of Results Storage3
− Serum 10 1 PV Isotonic saline1 or 1.0–14.0 mg/dL 8.4–10.2 mg/dL 2.10–2.55 mmol/L 680 1 ≤ 4 weeks Frozen or Refrigerated
Ca
− Heparin Reagent-grade 0.25–3.49 mmol/L
Calcium plasma water1 (mmol/L = mg/dL x 0.2495)
FS Diluent Pack 2 or
FS Diluent Pack 3
− Urine Reagent-grade 1.0–17.8 mg/dL Ca-free:
(pretreated) water1 0.25–4.44 mmol/L 5–40 mg/day 0.13–1.00
FS Diluent Pack 3 (mmol/L = mg/dL x 0.2495) mmol/day
Low to Average:
50–150 mg/day
1.25–3.75
Average: mmol/day
100–300 mg/day

2.50–7.50
mmol/day
− Serum 3.5 1 PV Isotonic saline1 or 1.0–14.0 mg/dL 8.6–10.3 mg/dL 2.15–2.57 mmol/L 680 1 ≤ 1 week Frozen or
XT Ca5
− Heparin Reagent-grade 0.25–3.49 mmol/L Refrigerated ≤ 4 months
Calcium (Lithium and water1 (mmol/L = mg/dL x 0.2495)
Sodium) FS Diluent Pack 2 or
plasma FS Diluent Pack 3

− Urine Reagent-grade 1.0–17.8 mg/dL Ca-free:

(pretreated) water1 0.25–4.44 mmol/L 5–40 mg/day 0.13–1.00
FS Diluent Pack 3 (mmol/L = mg/dL x 0.2495) mmol/day
Low to Average:
50–150 mg/day
1.25–3.75
Average: mmol/day
100–300 mg/day

2.50–7.50
mmol/day

This information was current as of the publication date. The Instructions for Use are the authorized source for information about VITROS Chemistry Products. Not all products and systems are available in all countries.
1
See Instructions for Use for the special dilution procedure.
2
See Instructions for Use for specimen Interferent information.
3
Minimum warm-up time to room temperature is 60 minutes if frozen and 30 minutes if refrigerated.
4
Minimum warm-up time for Na+ is 120 minutes if frozen and 90 minutes if refrigerated.
5
This assay is only approved for use on the VITROS XT 7600 Integrated System.

© Ortho-Clinical Diagnostics, Inc., 2020 • VITROS is a registered trademark of Ortho-Clinical Diagnostics, Inc. • 100 Indigo Creek Drive • Rochester, NY 14626 4
 VITROS® MicroSlide Assay Summary Pub. No. J23323_EN
2020-02-21

Reaction Sample

Recommended

Slide Supply

On-Analyzer
Volume (µL)
Specimens2

Filter (nm)
Calibrator
Suggested Reference Interval or

Stability
Control

Diluent
Measuring Cutoff
Test Name/ (Reportable or Dynamic) Refer to the Instructions for Use for Long-term Reagent
Abbreviation Range further Interpretation of Results Storage3
− Serum 11 6 PV 7% BSA 0.20–12.50 U/mL Male: 400 2 ≤4 weeks Frozen
CHE
− Heparin FS Diluent Pack 2 200–12500 U/L 5.90–12.22 U/mL 5900–12220 U/L
Cholinesterase
plasma2 (U/L = U/mL x 1000) Female:
4.65–10.44 U/mL 4650–10440 U/L
− Serum 5.5 2 PV 7% BSA 50–325 mg/dL Desirable: 540 1 ≤2 weeks Frozen or
CHOL
− Heparin FS Diluent Pack 2 1.29–8.40 mmol/L <200 mg/dL <5.2 mmol/L Refrigerated ≤ 6 months
Cholesterol plasma (mmol/L = mg/dL x 0.02586) Borderline High:
200–239 mg/dL 5.2–6.2 mmol/L
High:
≥240 mg/dL ≥6.2 mmol/L
− Serum 3.9 2 PV 7% BSA 50–325 mg/dL Desirable: 540 1 ≤1 week Frozen
XT CHOL5
− Heparin FS Diluent Pack 2 1.29–8.40 mmol/L <200 mg/dL <5.2 mmol/L
Cholesterol (Lithium and (mmol/L = mg/dL x 0.02586) Borderline High:
Sodium)
plasma 200–239 mg/dL 5.2–6.2 mmol/L
High:
≥240 mg/dL ≥6.2 mmol/L
− Serum 11 3 PV or 7% BSA 20–1600 U/L Female: 30–135 U/L 670 2 XT Frozen or
CK
− Heparin Iso- FS Diluent Pack 2 Male: 55–170 U/L 3400/4600/5,1 Refrigerated ≤4 weeks
Creatine Kinase plasma FS/5600/ XT
enzyme
PV 7600:
≤1 week

250/350:
≤2 days
– Serum 11 6 Iso- 7% BSA 2.7–300.0 U/L Refer to the CKMB Instructions for Use sheet 670 2 ≤1 week Frozen
CKMB
enzyme FS Diluent Pack 2
Creatine
PV
Kinase MB

This information was current as of the publication date. The Instructions for Use are the authorized source for information about VITROS Chemistry Products. Not all products and systems are available in all countries.
1
See Instructions for Use for the special dilution procedure.
2
See Instructions for Use for specimen Interferent information.
3
Minimum warm-up time to room temperature is 60 minutes if frozen and 30 minutes if refrigerated.
4
Minimum warm-up time for Na+ is 120 minutes if frozen and 90 minutes if refrigerated.
5
This assay is only approved for use on the VITROS XT 7600 Integrated System.

© Ortho-Clinical Diagnostics, Inc., 2020 • VITROS is a registered trademark of Ortho-Clinical Diagnostics, Inc. • 100 Indigo Creek Drive • Rochester, NY 14626 5
 VITROS® MicroSlide Assay Summary Pub. No. J23323_EN
2020-02-21

Reaction Sample

Recommended

Slide Supply

On-Analyzer
Volume (µL)
Specimens2

Filter (nm)
Calibrator
Suggested Reference Interval or

Stability
Control

Diluent
Measuring Cutoff
Test Name/ (Reportable or Dynamic) Refer to the Instructions for Use for Long-term Reagent
Abbreviation Range further Interpretation of Results Storage3
− Serum 10 2/ PV Do not dilute 50.0–175.0 mmol/L Adult: 98–107 mmol/L N/A 1 ≤2 weeks Frozen or Refrigerated
Cl-
Chloride − Li Heparin 32
plasma
− Urine N/A 15–300 mmol/L Urine (Random): 18–209 mmol/L
Urine (24-Hour): 110–250 mmol/Day
− Serum 11 9 TDM PV Do not dilute 3.0–20.0 μg/mL Therapeutic Range: 670 1 ≤1 week Frozen
CRBM
− Heparin 12.7–84.6 μmol/L 4.0–12.0 μg/mL 16.9–50.8 μmol/L
Carbamazepine (Lithium, (μmol/L = μg/mL x 4.23)
Sodium
heparin) and
Sodium
Citrate
plasma
− Serum 6 1 PV 7% BSA 0.15–14.0 mg/dL Male: 670 2 ≤2 weeks Frozen or
CREA
− Li Heparin FS Diluent Pack 2 13–1238 μmol/L 0.66–1.25 mg/dL 58–110 μmol/L Refrigerated ≤ 4 weeks
Creatinine plasma (μmol/L = mg/dL x 88.4) Female:
0.52–1.04 mg/dL 46–92 μmol/L
− Urine (diluted) Reagent-grade 3.2–346.5 mg/dL 24 Hour
water1 283–30631 μmol/L Male:
FS Diluent Pack 3 after x21 dilution with water 1000–2000 mg/day 8840–17680
(μmol/L = mg/dL x 88.4 ) Female: μmol/day
800–1800 mg/day
7072–15912
μmol/day

This information was current as of the publication date. The Instructions for Use are the authorized source for information about VITROS Chemistry Products. Not all products and systems are available in all countries.
1
See Instructions for Use for the special dilution procedure.
2
See Instructions for Use for specimen Interferent information.
3
Minimum warm-up time to room temperature is 60 minutes if frozen and 30 minutes if refrigerated.
4
Minimum warm-up time for Na+ is 120 minutes if frozen and 90 minutes if refrigerated.
5
This assay is only approved for use on the VITROS XT 7600 Integrated System.

© Ortho-Clinical Diagnostics, Inc., 2020 • VITROS is a registered trademark of Ortho-Clinical Diagnostics, Inc. • 100 Indigo Creek Drive • Rochester, NY 14626 6
 VITROS® MicroSlide Assay Summary Pub. No. J23323_EN
2020-02-21

Reaction Sample

Recommended

Slide Supply

On-Analyzer
Volume (µL)
Specimens2

Filter (nm)
Calibrator
Suggested Reference Interval or

Stability
Control

Diluent
Measuring Cutoff
Test Name/ (Reportable or Dynamic) Refer to the Instructions for Use for Long-term Reagent
Abbreviation Range further Interpretation of Results Storage3
− Serum 3.2 1 PV 7% BSA 0.15–14.0 mg/dL Male: 670 2 ≤2 weeks Frozen or
XT CREA5
− Heparin FS Diluent Pack 2 13–1238 μmol/L 0.66–1.25 mg/dL 58–110 μmol/L Refrigerated ≤ 4 weeks
Creatinine (Lithium and (μmol/L = mg/dL x 88.4) Female:
Sodium) 46–92 μmol/L
plasma 0.52–1.04 mg/dL

− Urine (diluted) Reagent-grade 3.2–346.5 mg/dL 24 Hour 8840–17680

water1 283–30631 μmol/L Male: μmol/day
FS Diluent Pack 3 after x21 dilution with water 1000–2000 mg/day
(μmol/L = mg/dL x 88.4 ) Female: 7072–15912
800–1800 mg/day μmol/day
− Serum 11 7 CRP PV Specialty Diluent or 5–90 mg/L <10 mg/L <1.0 mg/dL 670 1 ≤48 hours Frozen
CRP
− Heparin low patient sample 0.5–9.0 mg/dL
C-Reactive plasma FS Diluent Pack 3 (mg/dL = mg/L / 10)
Protein − EDTA plasma
− Serum 11 9 PV 7% BSA 0.40–4.00 ng/mL Therapeutic Range: 670 1 ≤1 week Frozen
DGXN
or FS Diluent Pack 2 0.51–5.12 nmol/L 0.8–2.0 ng/mL 1.0–2.6 nmol/L
Digoxin
TDM PV (nmol/L = ng/mL x 1.28)
− Serum 6 25 PV 7% BSA 5.0–110.0 mg/dL Low: 670 1 ≤7 days Frozen or
dHDL
− Heparin 0.13–2.84 mmol/L <40.0 mg/dL <1.03 mmol/L Refrigerated ≤12 weeks
Direct HDL plasma FS Diluent Pack 2
(mmol/L = mg/dL x 0.02586) High:
Cholesterol
≥60.0 mg/dL ≥1.55 mmol/L
− Serum 6 2/ PV Isotonic Saline 5.0–40.0 mmol/L 22–30 mmol/L 340 2 ≤4 weeks Frozen or Refrigerated
ECO2
− Heparin 32 FS Diluent Pack 2
Carbon Dioxide plasma
− Serum 10 4 PV Iron-free reagent- 10.1–600.0 μg/dL Female: 600 2 ≤4 weeks Frozen
Fe
− Heparin grade water 1.81–107.46 μmol/L 37–170 μg/dL 6.6–30.4 μmol/L
Iron plasma FS Diluent Pack 3 (μmol/L = μg/dL x 0.1791) Male:
49–181 μg/dL 8.8–32.4 μmol/L
− Serum 11 3 PV 7% BSA 10–1400 U/L Adult: 12–58 U/L 400 2 ≤4weeks Frozen or Refrigerated
GGT
− Heparin FS Diluent Pack 2 Female: 12–43 U/L
Gamma plasma
Glutamyltrans- ferase − EDTA plasma Male: 15–73 U/L

This information was current as of the publication date. The Instructions for Use are the authorized source for information about VITROS Chemistry Products. Not all products and systems are available in all countries.
1
See Instructions for Use for the special dilution procedure.
2
See Instructions for Use for specimen Interferent information.
3
Minimum warm-up time to room temperature is 60 minutes if frozen and 30 minutes if refrigerated.
4
Minimum warm-up time for Na+ is 120 minutes if frozen and 90 minutes if refrigerated.
5
This assay is only approved for use on the VITROS XT 7600 Integrated System.

© Ortho-Clinical Diagnostics, Inc., 2020 • VITROS is a registered trademark of Ortho-Clinical Diagnostics, Inc. • 100 Indigo Creek Drive • Rochester, NY 14626 7
 VITROS® MicroSlide Assay Summary Pub. No. J23323_EN
2020-02-21

Reaction Sample

Recommended

Slide Supply

On-Analyzer
Volume (µL)
Specimens2

Filter (nm)
Calibrator
Suggested Reference Interval or

Stability
Control

Diluent
Measuring Cutoff
Test Name/ (Reportable or Dynamic) Refer to the Instructions for Use for Long-term Reagent
Abbreviation Range further Interpretation of Results Storage3
− Serum 10 1 PV 7% BSA 20–625 mg/dL Fasting Adult: 540 2 ≤1 week Frozen or Refrigerated
GLU
− Heparin FS Diluent Pack 2 1.11–34.69 mmol/L 74–106 mg/dL 4.1–5.9 mmol/L
Glucose for Coatings (Lithium and
below 3200 (mmol/L = mg/dL x 0.05551) IMPORTANT
Sodium) When using sodium
plasma fluroride/potassium
− EDTA plasma oxalate specimen type:
− Sodium Refrigerated ≤4 months
Fluoride/
Potassium
oxalate
plasma
− Urine Isotonic saline or 20–650 mg/dL 24 Hour:
Reagent-grade 1.11–36.08 mmol/L <500 mg/day <2.8 mmol/day
water (mmol/L = mg/dL x 0.05551) Random:
FS Diluent Pack 2 or <30 mg/dL <1.7 mmol/L
FS Diluent Pack 3
− CSF2 Liquid 20–650 mg/dL 40–70 mg/dL 2.2–3.9 mmol/L
PV 1.11–36.08 mmol/L
(mmol/L = mg/dL x 0.05551)

This information was current as of the publication date. The Instructions for Use are the authorized source for information about VITROS Chemistry Products. Not all products and systems are available in all countries.
1
See Instructions for Use for the special dilution procedure.
2
See Instructions for Use for specimen Interferent information.
3
Minimum warm-up time to room temperature is 60 minutes if frozen and 30 minutes if refrigerated.
4
Minimum warm-up time for Na+ is 120 minutes if frozen and 90 minutes if refrigerated.
5
This assay is only approved for use on the VITROS XT 7600 Integrated System.

© Ortho-Clinical Diagnostics, Inc., 2020 • VITROS is a registered trademark of Ortho-Clinical Diagnostics, Inc. • 100 Indigo Creek Drive • Rochester, NY 14626 8
 VITROS® MicroSlide Assay Summary Pub. No. J23323_EN
2020-02-21

Reaction Sample

Recommended

Slide Supply

On-Analyzer
Volume (µL)
Specimens2

Filter (nm)
Calibrator
Suggested Reference Interval or

Stability
Control

Diluent
Measuring Cutoff
Test Name/ (Reportable or Dynamic) Refer to the Instructions for Use for Long-term Reagent
Abbreviation Range further Interpretation of Results Storage3
− Serum 6 1 PV 7% BSA 20.0–625.0 mg/dL Fasting Adult: 4.1–5.9 mmol/L 54 2 ≤1 week Frozen or Refrigerated
GLU 32 − Heparin 0
FS Diluent Pack 2 1.11–34.69 mmol/L 74–106 mg/dL
(Lithium and (mmol/L = mg/dL x 0.05551) IMPORTANT
Glucose for Coatings 3200
Sodium) When using sodium
and above
plasma fluroride/potassium
− EDTA plasma oxalate specimen type:
− Sodium
Refrigerated ≤4 months
Fluoride/
Potassium
oxalate
plasma
− Urine Isotonic saline or 20.0–650.0 mg/dL 24 Hour:
Reagent-grade water 1.11–36.08 mmol/L <500 mg/day <2.8 mmol/day
FS Diluent Pack 2 or (mmol/L = mg/dL x 0.05551) Random:
FS Diluent Pack 3 <30 mg/dL <1.7 mmol/L

− CSF Liquid 20.0–650.0 mg/dL 40–70 mg/dL 2.2–3.9 mmol/L

PV 1.11–36.08 mmol/L
(mmol/L = mg/dL x 0.05551)

This information was current as of the publication date. The Instructions for Use are the authorized source for information about VITROS Chemistry Products. Not all products and systems are available in all countries.
1
See Instructions for Use for the special dilution procedure.
2
See Instructions for Use for specimen Interferent information.
3
Minimum warm-up time to room temperature is 60 minutes if frozen and 30 minutes if refrigerated.
4
Minimum warm-up time for Na+ is 120 minutes if frozen and 90 minutes if refrigerated.
5
This assay is only approved for use on the VITROS XT 7600 Integrated System.

© Ortho-Clinical Diagnostics, Inc., 2020 • VITROS is a registered trademark of Ortho-Clinical Diagnostics, Inc. • 100 Indigo Creek Drive • Rochester, NY 14626 9
 VITROS® MicroSlide Assay Summary Pub. No. J23323_EN
2020-02-21

Reaction Sample

Recommended

Slide Supply

On-Analyzer
Volume (µL)
Specimens2

Filter (nm)
Calibrator
Suggested Reference Interval or

Stability
Control

Diluent
Measuring Cutoff
Test Name/ (Reportable or Dynamic) Refer to the Instructions for Use for Long-term Reagent
Abbreviation Range further Interpretation of Results Storage3
− Serum 2.7 1 PV 7% BSA 20–625 mg/dL Fasting Adult: 540 1 ≤1 week Frozen or
XT GLU5
− Heparin FS Diluent Pack 2 1.11–34.69 mmol/L 74–100 mg/dL 4.1–5.6 mmol/L Refrigerated ≤ 4 months
Glucose (Lithium and (mmol/L = mg/dL x 0.05551)
Sodium)
plasma
− Sodium
Fluoride/
Potassium
oxalate
plasma
− Urine Isotonic saline or 20–650 mg/dL 24 Hour:
Reagent-grade 1.11–36.08 mmol/L <500 mg/day <2.8 mmol/day
water (mmol/L = mg/dL x 0.05551) Random:
FS Diluent Pack 2 or 1-15 mg/dL 0.1-0.8 mmol/L
FS Diluent Pack 3
− CSF2 Liquid 20–650 mg/dL 40–70 mg/dL 2.2–3.9 mmol/L
PV 1.11–36.08 mmol/L
(mmol/L = mg/dL x 0.05551)
− Serum 10 2/ PV Do not dilute 1.00–14.00 mmol/L Serum: 3.5–5.1 mmol/L N/A 1 ≤2 weeks Frozen or Refrigerated
K+
− Heparin 32 Plasma: 0.1–0.7 mmol/L
plasma2 lower than serum
range
− Urine (diluted) Liquid PV Reagent-grade 2.50–175.00 mmol/L 24 Hour: 25.0–125.0
water1 after x5 dilution with UED mmol/day (diet
FS Diluent Pack 1 dependent)
− Heparin 10 1 PV Isotonic saline or 0.50–12.00 mmol/L 0.7–2.1 mmol/L 540 2 ≤2 weeks Frozen
LAC
plasma Reagent-grade
Lactate (keep whole water
blood on
ice) FS Diluent Pack 2 or
− Fluoride FS Diluent Pack 3
oxalate
plasma

This information was current as of the publication date. The Instructions for Use are the authorized source for information about VITROS Chemistry Products. Not all products and systems are available in all countries.
1
See Instructions for Use for the special dilution procedure.
2
See Instructions for Use for specimen Interferent information.
3
Minimum warm-up time to room temperature is 60 minutes if frozen and 30 minutes if refrigerated.
4
Minimum warm-up time for Na+ is 120 minutes if frozen and 90 minutes if refrigerated.
5
This assay is only approved for use on the VITROS XT 7600 Integrated System.

© Ortho-Clinical Diagnostics, Inc., 2020 • VITROS is a registered trademark of Ortho-Clinical Diagnostics, Inc. • 100 Indigo Creek Drive • Rochester, NY 14626 10
 VITROS® MicroSlide Assay Summary Pub. No. J23323_EN
2020-02-21

Reaction Sample

Recommended

Slide Supply

On-Analyzer
Volume (µL)
Specimens2

Filter (nm)
Calibrator
Suggested Reference Interval or

Stability
Control

Diluent
Measuring Cutoff
Test Name/ (Reportable or Dynamic) Refer to the Instructions for Use for Long-term Reagent
Abbreviation Range further Interpretation of Results Storage3
− Serum 11 3 PV 7% BSA 100–2150 U/L 313–618 U/L 340 2 ≤2 weeks Frozen or
LDH
− Heparin FS Diluent Pack 2 Refrigerated ≤ 4 weeks
Lactate plasma
Dehydrogenase
− Serum 11 3 PV 7% BSA 41–1000 U/L 120–246 U/L 340 2 ≤2 weeks Frozen or
LDHI
− Heparin FS Diluent Pack 2 Refrigerated ≤ 4 weeks
Lactate plasma
Dehydrogenase
− Serum 10 1 PV 7% BSA 0.20–4.00 mmol/L Therapeutic: 0.6–1.2 mmol/L 600 2 ≤5 weeks Frozen
Li
− Heparin FS Diluent Pack 2 Potentially Toxic: >1.5 mmol/L
Lithium plasma
− EDTA plasma Severely Toxic: >2.5 mmol/L
− Serum 5.5 3 PV 7% BSA 10–2000 U/L 23–300 U/L 540 1 ≤1 week Frozen
LIPA
− Heparin FS Diluent Pack 2
Lipase plasma
− Serum 5 1 PV Isotonic saline or 0.20–10.0 mg/dL 1.6–2.3 mg/dL 0.7–1.0 mmol/L 630 1 ≤2 weeks Frozen
Mg
− Heparin Reagent-grade 0.08–4.11 mmol/L
Magnesium plasma water (mmol/L = mg/dL x 0.4114)
FS Diluent Pack 2 or
FS Diluent Pack 3
− Urine Reagent-grade 1.20–60.0 mg/dL 24 Hour:
(pretreated, water 0.49–24.68 mmol/L 73.0–122.0 mg/day 3.0–5.0 mmol/day
diluted) FS Diluent Pack 3 after x6 dilution with water
(mmol/L = mg/dL x 0.4114)
− Serum 10 2/ PV Do not dilute 75.0–250.0 mmol/L 137–145 mmol/L N/A 1 ≤10 days Frozen or
Na+
− Heparin 32 Refrigerated4 ≤ 3 months
Sodium plasma
− Urine (diluted) Liquid PV Reagent-grade 5.0–250.0 mmol/L 24 Hour: 40–220 mmol/day
water after x5 dilution with Random: 30–90 mmol/L
FS Diluent Pack 1 UED

This information was current as of the publication date. The Instructions for Use are the authorized source for information about VITROS Chemistry Products. Not all products and systems are available in all countries.
1
See Instructions for Use for the special dilution procedure.
2
See Instructions for Use for specimen Interferent information.
3
Minimum warm-up time to room temperature is 60 minutes if frozen and 30 minutes if refrigerated.
4
Minimum warm-up time for Na+ is 120 minutes if frozen and 90 minutes if refrigerated.
5
This assay is only approved for use on the VITROS XT 7600 Integrated System.

© Ortho-Clinical Diagnostics, Inc., 2020 • VITROS is a registered trademark of Ortho-Clinical Diagnostics, Inc. • 100 Indigo Creek Drive • Rochester, NY 14626 11
 VITROS® MicroSlide Assay Summary Pub. No. J23323_EN
2020-02-21

Reaction Sample

Recommended

Slide Supply

On-Analyzer
Volume (µL)
Specimens2

Filter (nm)
Calibrator
Suggested Reference Interval or

Stability
Control

Diluent
Measuring Cutoff
Test Name/ (Reportable or Dynamic) Refer to the Instructions for Use for Long-term Reagent
Abbreviation Range further Interpretation of Results Storage3
− Serum 10 1 PV Isotonic saline or 0.50–13.00 mg/dL 2.5–4.5 mg/dL 0.81–1.45 mmol/L 680 1 ≤4 weeks Frozen or Refrigerated
PHOS
− Heparin Reagent-grade 0.16–4.20 mmol/L or
Phosphorous plasma 670
water (mmol/L = mg/dL x 0.3229)
FS Diluent Pack 2 or
FS Diluent Pack 3
− Urine Reagent-grade 5.50–143.00 mg/dL 24 hour:
(pretreated, water1 1.78–46.17 mmol/L 0.4–1.3 g/day 12.9–42.0
diluted) FS Diluent Pack 3 after x11 dilution with water mmol/day
(mmol/L = mg/dL x 0.3229)
− Serum 11 9 PV or 7% BSA 3.00–40.00 μg/mL Therapeutic Range: 670 1 ≤1 week Frozen
PHYT
− Heparin TDM PV FS Diluent Pack 2 11.88–158.40 μmol/L 10.0–20.0 μg/mL 39.6–79.2 μmol/L
Phenytoin plasma (μmol/L = μg/mL x 3.96)
− CSF 10 5 Liquid PV Isotonic saline 10–300 mg/dL CSF: 670 2 ≤1 week Frozen
PROT
FS Diluent Pack 2 100–3000 mg/L 12–60 mg/dL 120–600 mg/L
Cerebrospinal Fluid
(mg/L = mg/dL x 10)
Protein
− Serum 10 1 Liquid PV 7% BSA 1.0–40.0 mg/dL Negative: 540 2 ≤5 weeks Frozen
SALI
− Heparin FS Diluent Pack 2 0.07–2.90 mmol/L <2 mg/dL <0.1 mmol/L
Salicylate plasma (mmol/L = mg/dL x 0.0724) Therapeutic:
<20 mg/dL <1.5 mmol/L
Toxic:
>30 mg/dL >2.2 mmol/L
Lethal:
>60 mg/dL >4.3 mmol/L
− Serum 10 4 PV Reagent-grade 0.10–27.00 mg/dL 0.2–1.3 mg/dL 3–22 μmol/L 540 1 ≤2 weeks Frozen or Refrigerated
TBIL
− Li Heparin water 1.7–461.7 μmol/L &
Total Bilirubin plasma 460
FS Diluent Pack 3 (μmol/L = mg/dL x 17.1)

This information was current as of the publication date. The Instructions for Use are the authorized source for information about VITROS Chemistry Products. Not all products and systems are available in all countries.
1
See Instructions for Use for the special dilution procedure.
2
See Instructions for Use for specimen Interferent information.
3
Minimum warm-up time to room temperature is 60 minutes if frozen and 30 minutes if refrigerated.
4
Minimum warm-up time for Na+ is 120 minutes if frozen and 90 minutes if refrigerated.
5
This assay is only approved for use on the VITROS XT 7600 Integrated System.

© Ortho-Clinical Diagnostics, Inc., 2020 • VITROS is a registered trademark of Ortho-Clinical Diagnostics, Inc. • 100 Indigo Creek Drive • Rochester, NY 14626 12
 VITROS® MicroSlide Assay Summary Pub. No. J23323_EN
2020-02-21

Reaction Sample

Recommended

Slide Supply

On-Analyzer
Volume (µL)
Specimens2

Filter (nm)
Calibrator
Suggested Reference Interval or

Stability
Control

Diluent
Measuring Cutoff
Test Name/ (Reportable or Dynamic) Refer to the Instructions for Use for Long-term Reagent
Abbreviation Range further Interpretation of Results Storage3
− Serum 5.0 4 PV Reagent-grade 0.1–27.0 mg/dL 0.2–1.3 mg/dL 3–22 μmol/L 540 2 ≤2 weeks Frozen or Refrigerated
XT TBIL5
− Heparin water 1.7–461.7 μmol/L &
Total Bilirubin (Lithium and 460
FS Diluent Pack 3 (μmol/L = mg/dL x 17.1)
Sodium)
plasma

− Serum 10 1 PV 7% BSA 1.00–40.00 μg/mL 10.0–20.0 μg/mL 55.5–111.0 400 2 ≤1 week Frozen
THEO
− Heparin FS Diluent Pack 2 5.55–222.00 μmol/L μmol/L
Theophylline plasma (μmol/L = μg/mL x 5.55)

− Serum (pre- 10 4 PV Iron-free deionized 85–650 μg/dL Male: 600 Refer to ‘Fe’ on page 7
TIBC
treated) Water1 15.2–116.4 μmol/L 261–462 μg/dL 46.8–82.7 μmol/L
Total Iron-Binding
(μmol/L = μg/dL x 0.1791) Female:
Capacity
265–497 μg/dL 47.4–89.0 μmol/L

− Serum 6.5 4 PV Isotonic saline or 2.00–11.00 g/dL 6.3–8.2 g/dL 63–82 g/L 540 1 ≤4 weeks Frozen or Refrigerated
TP
− Heparin Reagent-grade 20.0–110.0 g/L
Total Protein plasma water (g/L = g/dL x 10.0)
FS Diluent Pack 2 or
FS Diluent Pack 3

− Serum 4.1 4 PV Isotonic saline or 2.0–11.0 g/dL 6.3–8.2 g/dL 63–82 g/L 540 1 ≤1 week Frozen or Refrigerated
XT TP5
− Heparin Reagent-grade 20–110 g/L
Total Protein (Lithium and water (g/L = g/dL x 10)
Sodium) FS Diluent Pack 2 or
plasma
FS Diluent Pack 3

This information was current as of the publication date. The Instructions for Use are the authorized source for information about VITROS Chemistry Products. Not all products and systems are available in all countries.
1
See Instructions for Use for the special dilution procedure.
2
See Instructions for Use for specimen Interferent information.
3
Minimum warm-up time to room temperature is 60 minutes if frozen and 30 minutes if refrigerated.
4
Minimum warm-up time for Na+ is 120 minutes if frozen and 90 minutes if refrigerated.
5
This assay is only approved for use on the VITROS XT 7600 Integrated System.

© Ortho-Clinical Diagnostics, Inc., 2020 • VITROS is a registered trademark of Ortho-Clinical Diagnostics, Inc. • 100 Indigo Creek Drive • Rochester, NY 14626 13
 VITROS® MicroSlide Assay Summary Pub. No. J23323_EN
2020-02-21

Reaction Sample

Recommended

Slide Supply

On-Analyzer
Volume (µL)
Specimens2

Filter (nm)
Calibrator
Suggested Reference Interval or

Stability
Control

Diluent
Measuring Cutoff
Test Name/ (Reportable or Dynamic) Refer to the Instructions for Use for Long-term Reagent
Abbreviation Range further Interpretation of Results Storage3
− Serum 5.5 2 PV 7% BSA 10–525 mg/dL Normal: 540 1 ≤1 week Frozen
TRIG
− Heparin FS Diluent Pack 2 0.11–5.93 mmol/L <150 mg/dL <1.69 mmol/L
Triglyceride plasma (mmol/L = mg/dL x 0.01129) Borderline High:
150–199 mg/dL 1.69–2.25 mmol/L
High:
200–499 mg/dL 2.26–5.64 mmol/L
Very High:
≥500 mg/dL ≥5.65 mmol/L

− Serum 2.9 2 PV 7% BSA 10–525 mg/dL Normal: 540 1 ≤1 week Frozen

XT TRIG5
− Heparin FS Diluent Pack 2 0.11–5.93 mmol/L <150 mg/dL <1.69 mmol/L
Triglyceride (Lithium and (mmol/L = mg/dL x 0.01129) Borderline High:
Sodium)
plasma 150–199 mg/dL 1.69–2.25 mmol/L
High:
200–499 mg/dL 2.26–5.64 mmol/L
Very High:
≥500 mg/dL ≥5.65 mmol/L

− Urine 10 10 UPRO PV Reagent-grade 5–200 mg/dL Random: 670 1 ≤2 weeks Frozen

UPRO
water1 0.05–2.00 g/L <12 mg/dL <0.12 g/L
Urine Protein
FS Diluent Pack 3 (g/L = mg/dL x 0.01) 24 Hour:
42–225 mg/day 0.04–0.23 g/day

This information was current as of the publication date. The Instructions for Use are the authorized source for information about VITROS Chemistry Products. Not all products and systems are available in all countries.
1
See Instructions for Use for the special dilution procedure.
2
See Instructions for Use for specimen Interferent information.
3
Minimum warm-up time to room temperature is 60 minutes if frozen and 30 minutes if refrigerated.
4
Minimum warm-up time for Na+ is 120 minutes if frozen and 90 minutes if refrigerated.
5
This assay is only approved for use on the VITROS XT 7600 Integrated System.

© Ortho-Clinical Diagnostics, Inc., 2020 • VITROS is a registered trademark of Ortho-Clinical Diagnostics, Inc. • 100 Indigo Creek Drive • Rochester, NY 14626 14
 VITROS® MicroSlide Assay Summary Pub. No. J23323_EN
2020-02-21

Reaction Sample

Recommended

Slide Supply

On-Analyzer
Volume (µL)
Specimens2

Filter (nm)
Calibrator
Suggested Reference Interval or

Stability
Control

Diluent
Measuring Cutoff
Test Name/ (Reportable or Dynamic) Refer to the Instructions for Use for Long-term Reagent
Abbreviation Range further Interpretation of Results Storage3
− Serum 10 1 PV 7% BSA 0.50–17.00 mg/dL Male: 670 1 ≤2 weeks Frozen or Refrigerated
URIC
− Heparin FS Diluent Pack 2 29.7–1011.2 μmol/L 3.5–8.5 mg/dL 208–506 μmol/L
Uric Acid plasma (μmol/L = mg/dL x 59.48) Female:
2.5–6.2 mg/dL 149–369 μmol/L
− Urine Reagent-grade 5.50–187.00 mg/dL 24 Hour:
(pretreated, water1 327.1–11122.8 μmol/L 250–750 mg/day 1480–4430
diluted) FS Diluent Pack 3 after x11 dilution with water μmol/day
(μmol/L = mg/dL x 59.48)

This information was current as of the publication date. The Instructions for Use are the authorized source for information about VITROS Chemistry Products. Not all products and systems are available in all countries.
1
See Instructions for Use for the special dilution procedure.
2
See Instructions for Use for specimen Interferent information.
3
Minimum warm-up time to room temperature is 60 minutes if frozen and 30 minutes if refrigerated.
4
Minimum warm-up time for Na+ is 120 minutes if frozen and 90 minutes if refrigerated.
5
This assay is only approved for use on the VITROS XT 7600 Integrated System.

© Ortho-Clinical Diagnostics, Inc., 2020 • VITROS is a registered trademark of Ortho-Clinical Diagnostics, Inc. • 100 Indigo Creek Drive • Rochester, NY 14626 15
VITROS® MicroSlide Assay Summary Pub. No. J23323_EN
2020-02-21

Derived Tests
Test Calculation Test Calculation
A/G Albumin/Globulin Ratio ALB / (TP - ALB) GLOB Globulin TP - ALB
Conv. Units: (CHOL - dHDL) - ( TRIG/5)
AGp Anion Gap without K+ (Na+) - (Cl- + ECO2) LDL Low Density Lipoprotein
SI Units: (CHOL - dHDL) - ( TRIG/2.2)
Anion Gap
AGpK (Na+ + K+) - (Cl- + ECO2) NBil Neonatal Bilirubin Bu + Bc
with K+
B/CR BUN/Creatinine Ratio BUN / CREA OSMO Osmolality (Na+ x 1.86) + (GLU/18) + (BUN/2.8)
Conv. Units: TRIG/5
C/H Cholesterol/ dHDL Ratio CHOL / dHDL VLDL Very Low Density Lipoprotein
SI Units: TRIG /2.2
(CKMB/CK) x 100
DBIL Direct Bilirubin TBIL - Bu % MB CKMB/CK Ratio

(Fe/TIBC) x 100
DELB Delta Bilirubin TBIL - (Bu + Bc) % Sat Percent Iron Saturation

This information was current as of the publication date. The Instructions for Use are the authorized source for information about VITROS Chemistry Products. Not all products and systems are available in all countries.
1
See Instructions for Use for the special dilution procedure.
2
See Instructions for Use for specimen Interferent information.
3
Minimum warm-up time to room temperature is 60 minutes if frozen and 30 minutes if refrigerated.
4
Minimum warm-up time for Na+ is 120 minutes if frozen and 90 minutes if refrigerated.
5
This assay is only approved for use on the VITROS XT 7600 Integrated System.

© Ortho-Clinical Diagnostics, Inc., 2020 • VITROS is a registered trademark of Ortho-Clinical Diagnostics, Inc. • 100 Indigo Creek Drive • Rochester, NY 14626 16